Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic...
Chronic Renal FailureChronic Kidney Disease1 moreThe purpose of the study was to evaluate the safety and efficacy of peginesatide in the maintenance treatment of anemia in participants on dialysis.
Omacor in Prevention of Cardiovascular Events in Patients Undergoing Chronic Hemodialysis
Kidney FailureChronicThe aim of this investigator initated study is to examine the effect of OMACOR (Omega-3-acid ethyl ester 90) on the incidence of cardiovascular events and mortality in patients undergoing chronic hemodialysis, who has previously experienced a cardiovascular event.
Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients...
AnemiaChronic Kidney Disease1 moreThe purpose of this study was to evaluate the safety, pharmacodynamics (PD), and pharmacokinetics (PK) of multiple subcutaneous injections of peginesatide in participants with chronic kidney disease (CKD) not on dialysis who had not received erythropoiesis stimulating agent (ESA) treatment.
Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients
AnemiaIron-Deficiency2 moreThis study compares the effect of Ferrlecit® (a form of intravenous iron) to ferrous sulfate (a form of oral iron) in treating anemia and iron deficiency in chronic kidney disease patients who are not receiving erythropoietic agents (hormones that stimulate the bone marrow to make more red blood cells).
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
AnemiaIron-Deficiency3 moreThis study explores the safety and efficacy of intravenous iron therapy in anemic hemodialysis patients treated with epoetin alfa, who have higher serum ferritin levels, but low to normal transferrin saturation.
Darbepoetin Treatment of Anemia in Children With Chronic Renal Failure
Kidney FailureChronicThis is a study to determine the safety and effectiveness of Darbepoetin (Aranesp) given every 14 to 28 days to treat low red blood cells in children with chronic kidney failure.
Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal...
Chronic Renal FailureChronic Kidney Disease1 moreThe purpose of this study was to evaluate the safety and efficacy of peginesatide for the treatment of anemia in participants with chronic kidney disease, who are not on dialysis and not on erythropoiesis stimulating agent (ESA) treatment.
Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency...
Diabetes MellitusType 22 moreThe purpose of the study is to compare how sitagliptin and glipizide lower blood glucose levels in participants with moderate or severe renal insufficiency.
STAAR-2 Clinical Study
Chronic Kidney DiseaseChronic Renal Insufficiency3 moreTo assess the effect of Aranesp on the hemoglobin (Hgb) of CRI subjects who are recombinant human erythropoietin (rHuEPO)-naïve or converting from rHuEPO therapy.
Pilot Study of Wearable Artificial Kidney
Renal FailureThis is a pilot study of a wearable type of kidney dialysis machine to treat patients with chronic kidney disease.